This edition of Basic Cardiovascular Sciences Scientific Sessions has already taken place.
Search future editions →Events › Healthcare & MedTech
Healthcare & MedTech
35
Exhibitors
1,000
Attendees
The Basic Cardiovascular Sciences (BCVS) Scientific Sessions is a premier global conference centered on fundamental and translational cardiovascular research. Organized by the American Heart Association, it highlights advancements in microRNAs, gene/cell therapies, and tissue engineering.
Exhibitor mix: The exhibition space is formatted as a singular boutique-style hall where biomedical vendors, research supply companies, and pharmaceutical labs showcase products near the poster session zones.
Filter this event to your ICP.
35 exhibitors here. You probably care about 20–30. Tell us your ICP, we'll find them.
Request intelligence →Delivery within 24 hours · $1,250
⚠️ The exhibitor list for this event isn't publicly accessible yet. We'll work on it once you submit a request.
Venue
Sheraton Boston HotelHotel venue · 5,744 m² · 26 halls · ~3,000 people
A 1,070-room hotel located in Boston's Back Bay, featuring over 61,000 sq ft of meeting space across 26 rooms, with direct access to the Hynes Convention Center.
📍 39 Dalton St, Boston, MA 02199, USA
Operated by Marriott International
Organizer
American Heart AssociationNonprofit · Dallas, United States · Founded 1924
A national non-profit organization dedicating funds to cardiovascular medical research, patient care, and education.
Why people attend
Leading scientific investigators, laboratory directors, and clinical trialists attend to evaluate cutting-edge molecular biology technologies, specialized laboratory equipment, and contract research services.
Who attends
Exhibitor categories
Sample matches
Filtered to a Series-B SaaS ICP. Your filter will be different.
Sample Match A
example.com
"Strong ICP match: Series B, EU expansion, VP Engineering and CTO attending."
Sample Match B
example.io
"Mid-stage SaaS with active GTM motion; product-led growth signals align with ICP."
████████ ██████
████████.io
"████████████████████████████████████████."
Submit your ICP
to unlock all matches
████████ ██████
████████.io
"████████████████████████████████████████."
Submit your ICP
to unlock all matches
Speakers
217 speakers at Basic Cardiovascular Sciences Scientific Sessions
"Commentary: It’s Never Too Late and It’s Never Too Early to Save your Brain"
"Commentary: It’s Never Too Late and It’s Never Too Early to Save your Brain"
"CS.05 Results of ODYSSEY"
"CS.05 Results of ODYSSEY"
"Commentary: Familial Hypercholesterolemia: Our Call to Action"
Ford Professor of Economics · MIT Department of Economics
"Intentions are Good, Instrumental Variables is Better: Addressing Nonadherence and Crossovers in Clinical Trials"
Joshua David Angrist is an Israeli American economist and Ford Professor of Economics at the Massachusetts Institute of Technology. Angrist, together with Guido Imbens, was awarded the Nobel Memorial Prize in Economics in 2021 "for methodological contributions to the analysis of causal relationships".
Professor of Interventional Medicine & Innovation · University of Galway
"Coronary Revascularization in 2040"
Professor Patrick W. Serruys is a world-renowned expert in interventional cardiology and imaging with more than four decades of experience in clinical trials and innovation in medicine. He has pioneered several interventional procedures and devices such as BMS, DES, BRS and TAVI, as well as imaging techniques including quantitative coronary angiography, quantitative IVUS, OCT, near spectroscopy combined with IVUS. In parallel, he has developed an interest for non-invasive imaging of coronary artery disease combining anatomy and functional assessments of CCTA.
Chair, Scientific Sessions American Heart Association · Cedars Sinai Medical Center
Brahmajee Nallamothu, MD, MPH, FAHA
Vice-Chair, Scientific Sessions American Heart Association · University of Michigan
Duke University Hospital
"Comparative Effectiveness of Torsemide versus Furosemide in Heart Failure: Primary Results of the TRANSFORM-HF Trial"
Minneapolis VA Health Care System
"Chlorthalidone Compared to Hydrochlorothiazide for the Prevention of Cardiovascular Events in Patients With Hypertension"
Brigham and Women's Hospital
"A Randomized Trial of Pemafibrate for Triglyceride Reduction in the Prevention of Cardiovascular Disease"
University College of London
"First-in-Human in vivo CRISPR/Cas9 Editing of the TTR Gene by NTLA-2001 in Patients With Transthyretin Amyloidosis With Cardiomyopathy"
Portsmouth Hospital, University NHS Trust
"A Randomized Trial of Intravenous Ferric Derisomaltose in Heart Failure With Reduced Ejection Fraction"
Duke Pediatric and Adult Congenital Heart Center
"Steroids to Reduce Systemic Inflammation After Infant Heart Surgery: The STRESS Trial"
Brown University
"The Effect of Adapted Mindfulness Training in Participants With Elevated Office Blood Pressure: The Mindfulness-Based Blood Pressure Reduction (MB-BP) Randomized Clinical Trial"
+ 201 more speakers at this event.
More Healthcare & MedTech events
Frequently asked questions